Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response to Hepatitis A Vaccine”

67 trials

Showing 20 of 67 results

Testing effectiveness (Phase 2)Study completedNCT00429481
What this trial is testing

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants

Who this might be right for
Hepatitis B
GlaxoSmithKline 2,464
Not applicableEnded earlyNCT02166671
What this trial is testing

Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years

Who this might be right for
Hepatitis B Vaccination
Seoul National University Hospital 9
Not applicableStudy completedNCT00142740
What this trial is testing

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Who this might be right for
HIV InfectionHepatitis B
University of North Carolina, Chapel Hill 337
Testing effectiveness (Phase 2)Study completedNCT00886964
What this trial is testing

Hepatitis B Vaccination (HBV) in HIV Infected Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 80
Post-approval studies (Phase 4)Active Not RecruitingNCT04674462
What this trial is testing

Understanding Poor Vaccine Responses to Hepatitis B Vaccination

Who this might be right for
Vaccine Reaction
NYU Langone Health 101
Large-scale testing (Phase 3)Study completedNCT00197184
What this trial is testing

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline 276
Early research (Phase 1)Study completedNCT00426712
What this trial is testing

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 42
Large-scale testing (Phase 3)Study completedNCT00291343
What this trial is testing

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 296
Early research (Phase 1)Looking for participantsNCT04843852
What this trial is testing

TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hepatitis B
University of Maryland, Baltimore 10
Post-approval studies (Phase 4)Study completedNCT00197158
What this trial is testing

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Who this might be right for
Hepatitis B
GlaxoSmithKline 280
Testing effectiveness (Phase 2)Study completedNCT02692170
What this trial is testing

Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine

Who this might be right for
Healthy
CHA Vaccine Institute Co., Ltd. 75
Testing effectiveness (Phase 2)Study completedNCT02041325
What this trial is testing

Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias

Who this might be right for
Plasma Cell Disorder
Boston VA Research Institute, Inc. 38
Post-approval studies (Phase 4)Study completedNCT00335881
What this trial is testing

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Who this might be right for
Hepatitis B
GlaxoSmithKline 300
Post-approval studies (Phase 4)Study completedNCT01333813
What this trial is testing

Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children

Who this might be right for
Hepatitis B
GlaxoSmithKline 300
Not applicableStudy completedNCT00138268
What this trial is testing

Pilot Study Freeze and Transport Immune Cells

Who this might be right for
DiphtheriaHepatitis BPertussis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 12
Testing effectiveness (Phase 2)Study completedNCT03685708
What this trial is testing

HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
HepatitisSafety and Tolerability
National Heart, Lung, and Blood Institute (NHLBI) 78
Post-approval studies (Phase 4)UnknownNCT04326803
What this trial is testing

Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response

Who this might be right for
Hepatitis B
Pontificia Universidad Catolica de Chile 200
Post-approval studies (Phase 4)Study completedNCT00657657
What this trial is testing

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 29
Not applicableStudy completedNCT00141999
What this trial is testing

Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents

Who this might be right for
Hepatitis
Centers for Disease Control and Prevention 400
Post-approval studies (Phase 4)Study completedNCT00984139
What this trial is testing

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

Who this might be right for
Hepatitis B
GlaxoSmithKline 306
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation